Firm

Wu Xiaoping of Wanhuida Intellectual Property says the methodology often applied in assessing inventiveness in pharmaceutical patent litigation cases is set to be used in re-examination and invalidation proceedings after the CNIPA makes an invalidation decision a quasi-precedent

Managing IP sat down with Patrik Lindahl of Zacco and Alessandra Vercelloni of OpSec to learn about the often-overlooked threat to brands posed by the grey market and parallel imports

Prior art searches play a critical role in shaping effective scientific intellectual property strategies. This article, originally published by CAS, highlights the importance of thorough analysis to safeguard R&D investments and ensure patentability

Join Managing IP and CAS at 3pm GMT (4pm CET) on December 4 to hear scientific intellectual property search experts explain how a tailored freedom-to-operate analysis can help avoid infringement and facilitate the path to market

Charles Feng of Tahota Law Firm begins a two-part guide to intellectual property protection in China by considering the general provisions, before focusing on the key issues and legal framework concerning trademarks

Charles Feng of Tahota Law Firm concludes a two-part series on intellectual property protection in China by looking at copyright, unfair competition, and a change to the appeals procedure for technology-related disputes